Spinal or Epidural Fentanyl or Sufentanil for Labour Pain in Early Phase of the Labour
2 other identifiers
interventional
80
1 country
1
Brief Summary
In this study the analgesic effect of two different opioids (fentanyl and sufentanil) will be compared when given either intrathecally or epidurally in primiparous parturients during early phase of the labour.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Sep 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 26, 2016
CompletedFirst Posted
Study publicly available on registry
August 31, 2016
CompletedStudy Start
First participant enrolled
September 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2018
CompletedResults Posted
Study results publicly available
May 19, 2021
CompletedJune 10, 2021
May 1, 2021
1.7 years
August 26, 2016
March 31, 2021
May 27, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Change of Maximum Pain During Contraction at 20 Minutes After the Study Drug Delivery
All parturients are to have a pain visual analog scale (VAS - on a 0-100 mm scale) at 80mm or higher before the initial study drug delivery. On this scale 0 mm presents a totally pain free condition while 100 mm presents the worst imaginable pain. The change of maximum pain in millimeters on the VAS scale during the 20 minutes following the study drug delivery will be recorded.
20 minutes
Secondary Outcomes (1)
The Duration of Labour Analgesia After the Single Dose of Epidural or Intrathecal Opioid
The data below report an average duration of time that is typically less than three hours
Study Arms (4)
Spinal fentanyl
ACTIVE COMPARATOR20 micrograms of intrathecally administered fentanyl in single dose. Total volume of intrathecal injection 2 ml.
Epidural fentanyl
EXPERIMENTAL100 micrograms of epidurally administered fentanyl in a single dose. Total volume of epidural injection 7 ml.
Spinal sufentanil
ACTIVE COMPARATOR5 micrograms of intrathecally administered sufentanil in a single dose. Total volume of intrathecal injection 2 ml.
Epidural sufentanil
EXPERIMENTAL20 micrograms of epidurally administered sufentanil in a single dose. Total volume of epidural injection 7 ml.
Interventions
Intrathecal dose of either fentanyl or sufentanil delivered by combined spinal-epidural technique
Epidural dose of either fentanyl or sufentanil delivered through an epidural catheter.
Eligibility Criteria
You may qualify if:
- Primiparous parturients
- In early phase of labour (cervical dilatation at or under 5 cm)
- No prior opioids by any route of administration within past 120 min
- Pain at or over 80 mm on 0-100 mm visual analog scale during contraction
You may not qualify if:
- Allergy for any of the medications used
- Contraindications for epidural/spinal analgesia
- BMI at the time of delivery under 20 or over 35 kg/m2
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maternity Hospital, Helsinki University Central Hospital
Helsinki, Uusimaa, FI-00610, Finland
Related Publications (1)
Vaananen A, Kuukasjarvi M, Tekay A, Ahonen J. Spinal and epidural sufentanil and fentanyl in early labour. Acta Anaesthesiol Scand. 2019 Nov;63(10):1413-1418. doi: 10.1111/aas.13450. Epub 2019 Jul 23.
PMID: 31286476RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
No known limitations.
Results Point of Contact
- Title
- Dr Antti Vaananen
- Organization
- Helsinki University Central hospital/Women's hospital/anaesthesia
Study Officials
- PRINCIPAL INVESTIGATOR
Antti J Vaananen, M.D., Ph.D.
Helsinki University Central Hospital (Katiloopiston sairaala)
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, Ph.D.
Study Record Dates
First Submitted
August 26, 2016
First Posted
August 31, 2016
Study Start
September 1, 2016
Primary Completion
May 1, 2018
Study Completion
May 1, 2018
Last Updated
June 10, 2021
Results First Posted
May 19, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share